Trials / Completed
CompletedNCT01584206
Sitosterolemia Metabolism
Assessment of Sterol Metabolism in Sitosterolemia: A Pilot Study of Patients Treated With Ezetimibe
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 16 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
Ezetimibe has become the treatment choice for patients with sitosterolemia. Ezetimibe is an inhibitor of cholesterol absorption from the gastrointestinal tract. The purpose of this study is to determine if ezetimibe improves whole body plant sterol and cholesterol homeostasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ezetimibe | 10mg ezetimibe/day, at least 4 months |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2013-08-01
- Completion
- 2016-12-01
- First posted
- 2012-04-24
- Last updated
- 2020-01-30
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01584206. Inclusion in this directory is not an endorsement.